应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ALRN Aileron Therapeutics Inc
盘前交易 07-17 04:38:00 EDT
3.09
+0.11
+3.69%
最高
3.10
最低
2.93
成交量
3.76万
今开
2.93
昨收
2.98
日振幅
5.70%
总市值
6,679万
流通市值
5,987万
总股本
2,161万
成交额
11.42万
换手率
0.19%
流通股本
1,937万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Aileron Therapeutics, Inc.盘中异动 股价大涨5.18%报3.25美元
自选股智能写手 · 07-13
Aileron Therapeutics, Inc.盘中异动 股价大涨5.18%报3.25美元
Aileron Therapeutics, Inc.盘中异动 股价大跌6.82%报2.87美元
自选股智能写手 · 06-25
Aileron Therapeutics, Inc.盘中异动 股价大跌6.82%报2.87美元
Aileron Therapeutics, Inc.盘中异动 早盘股价大涨5.11%
自选股智能写手 · 06-05
Aileron Therapeutics, Inc.盘中异动 早盘股价大涨5.11%
Aileron Therapeutics, Inc.盘中异动 急速跳水5.41%
自选股智能写手 · 05-29
Aileron Therapeutics, Inc.盘中异动 急速跳水5.41%
Aileron Therapeutics Inc 预计每股亏损 14 美分 - 财报前瞻
Reuters · 05-11
Aileron Therapeutics Inc 预计每股亏损 14 美分 - 财报前瞻
Aileron Therapeutics, Inc.盘中异动 早盘急速下挫6.85%报3.40美元
自选股智能写手 · 05-09
Aileron Therapeutics, Inc.盘中异动 早盘急速下挫6.85%报3.40美元
Aileron Therapeutics, Inc.盘中异动 股价大跌5.95%报3.72美元
自选股智能写手 · 05-08
Aileron Therapeutics, Inc.盘中异动 股价大跌5.95%报3.72美元
Aileron Therapeutics, Inc.盘中异动 早盘股价大涨6.97%报4.09美元
自选股智能写手 · 05-03
Aileron Therapeutics, Inc.盘中异动 早盘股价大涨6.97%报4.09美元
Aileron Therapeutics, Inc.盘中异动 早盘大幅下跌5.05%
自选股智能写手 · 05-02
Aileron Therapeutics, Inc.盘中异动 早盘大幅下跌5.05%
Aileron Therapeutics, Inc.盘中异动 股价大跌5.49%
自选股智能写手 · 05-01
Aileron Therapeutics, Inc.盘中异动 股价大跌5.49%
Aileron Therapeutics, Inc.盘中异动 急速下跌5.01%报4.51美元
自选股智能写手 · 04-23
Aileron Therapeutics, Inc.盘中异动 急速下跌5.01%报4.51美元
Aileron Therapeutics, Inc.盘中异动 股价大跌7.27%
自选股智能写手 · 04-20
Aileron Therapeutics, Inc.盘中异动 股价大跌7.27%
Aileron Therapeutics, Inc.盘中异动 快速拉升15.29%报4.90美元
自选股智能写手 · 04-18
Aileron Therapeutics, Inc.盘中异动 快速拉升15.29%报4.90美元
Aileron Therapeutics, Inc.盘中异动 早盘急速跳水5.05%报5.08美元
自选股智能写手 · 04-17
Aileron Therapeutics, Inc.盘中异动 早盘急速跳水5.05%报5.08美元
Aileron Therapeutics(ALRN.US):2023年Q4财报实现营收0美元,前值为0美元;每股收益为-1.54美元,前值为-1.02美元。
智通财经 · 04-16
Aileron Therapeutics(ALRN.US):2023年Q4财报实现营收0美元,前值为0美元;每股收益为-1.54美元,前值为-1.02美元。
Aileron Therapeutics Inc 报告截至 12 月的季度业绩 - 收益摘要
Reuters · 04-16
Aileron Therapeutics Inc 报告截至 12 月的季度业绩 - 收益摘要
Aileron Therapeutics, Inc.盘中异动 早盘股价大跌6.84%
自选股智能写手 · 04-15
Aileron Therapeutics, Inc.盘中异动 早盘股价大跌6.84%
Aileron Therapeutics, Inc.盘中异动 快速跳水6.07%
自选股智能写手 · 03-28
Aileron Therapeutics, Inc.盘中异动 快速跳水6.07%
Aileron Therapeutics, Inc.盘中异动 股价大跌8.63%报5.67美元
自选股智能写手 · 03-26
Aileron Therapeutics, Inc.盘中异动 股价大跌8.63%报5.67美元
Aileron Therapeutics, Inc.盘中异动 急速拉升5.47%报5.98美元
自选股智能写手 · 03-22
Aileron Therapeutics, Inc.盘中异动 急速拉升5.47%报5.98美元
暂无数据
公司概况
公司名称:
Aileron Therapeutics Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Aileron Therapeutics, Inc.于2001年8月6日根据特拉华州的法律成立为Renegade Therapeutics,Inc.,于2006年开始主营业务。2007年2月,公司修改其注册证书,将其名称改为Aileron Therapeutics ,Inc.该公司是一家临床阶段的生物制药公司,专注于开发和商业化一类新型的治疗剂,称为装订肽。该公司的首席候选产品ALRN-6924针对肿瘤抑制基因p53来治疗各种各样的癌症。目前正在多个临床试验中测试的ALRN-6924通过靶向两种初级p53抑制蛋白MDMX和MDM2来重新激活p53介导的肿瘤抑制。该公司正在进行的ALRN-6924临床试验包括用于治疗晚期实体瘤或淋巴瘤的第1期试验,用于治疗外周T细胞淋巴瘤的2a期试验,或PTCL治疗急性期的1期试验骨髓性白血病或AML和晚期骨髓增生异常综合征或MDS,作为单一疗法和用于治疗与胞嘧啶阿拉伯糖苷或Ara-C组合的AML / MDS的1b期试验。
发行价格:
--
{"stockData":{"symbol":"ALRN","market":"US","secType":"STK","nameCN":"Aileron Therapeutics Inc","latestPrice":3.09,"timestamp":1721160000000,"preClose":2.98,"halted":0,"volume":37576,"delay":0,"floatShares":19373884,"shares":21614847,"eps":-3.261674,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.11,"latestTime":"07-17 04:38:00 EDT","open":2.93,"high":3.1,"low":2.93,"amount":114171.444464,"amplitude":0.057047,"askPrice":4.94,"askSize":200,"bidPrice":1.24,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-3.261674,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721223000000},"adr":0,"listingDate":1498708800000,"adjPreClose":3.09,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":3.09,"preClose":3.09,"latestTime":"16:00 EDT","volume":134,"amount":414.06,"timestamp":1721160001801},"volumeRatio":0.39925198678250706},"requestUrl":"/m/hq/s/ALRN/tweets","defaultTab":"tweets","newsList":[{"id":"2451554784","title":"Aileron Therapeutics, Inc.盘中异动 股价大涨5.18%报3.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451554784","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451554784?lang=zh_cn&edition=full","pubTime":"2024-07-13 02:21","pubTimestamp":1720808506,"startTime":"0","endTime":"0","summary":"北京时间2024年07月13日02时21分,Aileron Therapeutics, Inc.股票出现异动,股价快速上涨5.18%。截至发稿,该股报3.25美元/股,成交量8161股,换手率0.04%,振幅6.15%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.51%。其相关个股中,Zura Bio Limited C/Wts 、Qualigen Therapeutics, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Qualigen Therapeutics, Inc.、Soligenix, Inc.、Xortx Therapeutics Inc.较为活跃,换手率分别为4028.92%、116.90%、100.43%,振幅较大的相关个股有Qualigen Therapeutics, Inc.、Xortx Therapeutics Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ,振幅分别为147.88%、78.88%、65.30%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407130221469681c6f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407130221469681c6f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALRN","LENZ","BK4139"],"gpt_icon":0},{"id":"2446150840","title":"Aileron Therapeutics, Inc.盘中异动 股价大跌6.82%报2.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446150840","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446150840?lang=zh_cn&edition=full","pubTime":"2024-06-25 22:49","pubTimestamp":1719326974,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日22时49分,Aileron Therapeutics, Inc.股票出现异动,股价快速跳水6.82%。截至发稿,该股报2.87美元/股,成交量3458股,换手率0.02%,振幅0.97%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.82%。其相关个股中,Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Estrella Immunopharma Inc C/Wts 29/09/2028、Glycomimetics, Inc.涨幅较大,Cns Pharmaceuticals, Inc.、Effector Therapeutics, Inc.、Glycomimetics, Inc.较为活跃,换手率分别为204.65%、186.60%、155.83%,振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Glycomimetics, Inc.、Effector Therapeutics, Inc.,振幅分别为67.71%、37.88%、34.28%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062522493596816a8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062522493596816a8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ALRN"],"gpt_icon":0},{"id":"2441270404","title":"Aileron Therapeutics, Inc.盘中异动 早盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441270404","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441270404?lang=zh_cn&edition=full","pubTime":"2024-06-05 22:59","pubTimestamp":1717599597,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日22时59分,Aileron Therapeutics, Inc.股票出现波动,股价快速拉升5.11%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.19%。其相关个股中,Virios Therapeutics, Inc.、Kineta, Inc.、诺瓦瓦克斯医药涨幅较大,Cns Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc、诺瓦瓦克斯医药较为活跃,换手率分别为58.17%、49.29%、12.39%,振幅较大的相关个股有Kineta, Inc.、Virios Therapeutics, Inc.、Biocardia Inc C/Wts 06/08/2024,振幅分别为63.28%、44.98%、41.80%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605225957941ec9a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605225957941ec9a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALRN"],"gpt_icon":0},{"id":"2439873845","title":"Aileron Therapeutics, Inc.盘中异动 急速跳水5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439873845","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439873845?lang=zh_cn&edition=full","pubTime":"2024-05-29 03:45","pubTimestamp":1716925532,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日03时45分,Aileron Therapeutics, Inc.股票出现波动,股价急速下挫5.41%。截至发稿,该股报3.32美元/股,成交量7.3163万股,换手率0.34%,振幅6.98%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.71%。其相关个股中,Insmed Incorporated、Calliditas Therapeutics Ab、Artelo Biosciences Inc C/Wts 20/06/2024 涨幅较大,Mustang Bio, Inc.、Exicure, Inc.、Kintara Therapeutics, Inc.较为活跃,换手率分别为92.17%、63.46%、47.30%,振幅较大的相关个股有Tc Biopharm Plc C/Wts 10/02/2028 、Exicure, Inc.、Biocardia Inc C/Wts 06/08/2024,振幅分别为89.11%、84.88%、52.98%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529034532aef21fd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529034532aef21fd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALRN","LENZ","BK4139"],"gpt_icon":0},{"id":"2434890067","title":"Aileron Therapeutics Inc 预计每股亏损 14 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434890067","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434890067?lang=zh_cn&edition=full","pubTime":"2024-05-11 06:45","pubTimestamp":1715381110,"startTime":"0","endTime":"0","summary":" * Aileron Therapeutics Inc 预计将于5月13日公布截至2024年3月31日的财报(预计) * * LSEG分析师对Aileron Therapeutics Inc的平均预期是每股亏损14美分。* 分析师对该公司股票的评级为 \"强力买入\"。* 在过去三个月中,分析师的平均盈利预期保持不变。* 华尔街对 Aileron Therapeutics Inc 的 12 个月目标价中位数为 19.00 美元,高于其上一次收盘价 3.82 美元。5月10日 - 本摘要于北京时间 5 月 10 日 22:44 机器生成。除非另有说明,所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALRN","LENZ"],"gpt_icon":0},{"id":"2434013313","title":"Aileron Therapeutics, Inc.盘中异动 早盘急速下挫6.85%报3.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434013313","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434013313?lang=zh_cn&edition=full","pubTime":"2024-05-09 21:41","pubTimestamp":1715262105,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日21时41分,Aileron Therapeutics, Inc.股票出现异动,股价大幅下跌6.85%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.16%。其相关个股中,Sab Biotherapeutics Inc C/Wts 22/10/2026 、再鼎医药、Notable Labs, Ltd.涨幅较大,Allarity Therapeutics, Inc.、Cytomx Therapeutics, Inc.、Alzamend Neuro, Inc.较为活跃,换手率分别为42.42%、16.32%、4.36%,振幅较大的相关个股有Notable Labs, Ltd.、180 Life Sciences Corp C/Wts 07/11/2025、Alzamend Neuro, Inc.,振幅分别为27.83%、21.74%、13.26%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509214146861ec1b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509214146861ec1b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALRN","BK4139"],"gpt_icon":0},{"id":"2433119735","title":"Aileron Therapeutics, Inc.盘中异动 股价大跌5.95%报3.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433119735","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433119735?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:50","pubTimestamp":1715104213,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日01时50分,Aileron Therapeutics, Inc.股票出现波动,股价大幅下跌5.95%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.81%。其相关个股中,Revelation Biosciences Inc C/Wts 10/01/2027 、Oragenics Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大,Clearmind Medicine Inc.、Allarity Therapeutics, Inc.、Tc Biopharm Plc较为活跃,换手率分别为1458.02%、254.90%、193.11%,振幅较大的相关个股有Revelation Biosciences Inc C/Wts 10/01/2027 、Psyence Biomedical Ltd C/Wts 25/01/2029、Avenue Therapeutics, Inc.,振幅分别为96.50%、56.63%、42.73%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508015013861eb860&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508015013861eb860&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALRN","BK4139"],"gpt_icon":0},{"id":"2432908203","title":"Aileron Therapeutics, Inc.盘中异动 早盘股价大涨6.97%报4.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432908203","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432908203?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:44","pubTimestamp":1714743872,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时44分,Aileron Therapeutics, Inc.股票出现异动,股价急速拉升6.97%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.29%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc是一家临床阶段的生物制药公司。消息层面,截至21时44分,《Form 144 | Aileron Therapeutics股东拟出售72.4万股股份,价值约361.99万美元》资讯为影响Aileron Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032144337a57fb87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032144337a57fb87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALRN","BK4139"],"gpt_icon":0},{"id":"2432602032","title":"Aileron Therapeutics, Inc.盘中异动 早盘大幅下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432602032","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432602032?lang=zh_cn&edition=full","pubTime":"2024-05-02 21:43","pubTimestamp":1714657395,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日21时43分,Aileron Therapeutics, Inc.股票出现波动,股价大幅下挫5.05%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.37%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc是一家临床阶段的生物制药公司。消息层面,截至21时43分,《Form 144 | Aileron Therapeutics股东拟出售72.4万股股份,价值约361.99万美元》资讯为影响Aileron Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502214315861eab0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502214315861eab0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALRN","BK4139","LENZ"],"gpt_icon":0},{"id":"2432230103","title":"Aileron Therapeutics, Inc.盘中异动 股价大跌5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432230103","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432230103?lang=zh_cn&edition=full","pubTime":"2024-05-01 01:56","pubTimestamp":1714499762,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日01时56分,Aileron Therapeutics, Inc.股票出现异动,股价大幅跳水5.49%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.27%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc是一家临床阶段的生物制药公司。消息层面,截至01时56分,《Form 144 | Aileron Therapeutics股东拟出售72.4万股股份,价值约361.99万美元》资讯为影响Aileron Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050101560387e85200&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050101560387e85200&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALRN","BK4139","LENZ"],"gpt_icon":0},{"id":"2429113689","title":"Aileron Therapeutics, Inc.盘中异动 急速下跌5.01%报4.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429113689","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429113689?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:50","pubTimestamp":1713880227,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时50分,Aileron Therapeutics, Inc.股票出现异动,股价大幅跳水5.01%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.12%。其相关个股中,Palisade Bio, Inc.、Carmell Corporation、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd涨幅较大,Palisade Bio, Inc.、Silo Pharma, Inc.、Nkgen Biotech, Inc.较为活跃,换手率分别为1396.39%、164.73%、25.01%,振幅较大的相关个股有Palisade Bio, Inc.、Moolec Science Sa C/Wts 、Immunitybio, Inc.,振幅分别为32.86%、23.24%、22.47%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发用于治疗癌症和其他疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232150277a54ee5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232150277a54ee5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALRN"],"gpt_icon":0},{"id":"2428266295","title":"Aileron Therapeutics, Inc.盘中异动 股价大跌7.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428266295","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428266295?lang=zh_cn&edition=full","pubTime":"2024-04-20 01:05","pubTimestamp":1713546306,"startTime":"0","endTime":"0","summary":"北京时间2024年04月20日01时05分,Aileron Therapeutics, Inc.股票出现波动,股价快速跳水7.27%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.08%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发用于治疗癌症和其他疾病的新型疗法。该信息摘要如下:Ladenburg Thalmann:维持Aileron Therapeutics评级,由买入调整至买入评级, 目标价由9.00美元调整至19.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200105067a5427b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200105067a5427b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ALRN"],"gpt_icon":0},{"id":"2428594246","title":"Aileron Therapeutics, Inc.盘中异动 快速拉升15.29%报4.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428594246","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428594246?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:32","pubTimestamp":1713447135,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日21时32分,Aileron Therapeutics, Inc.股票出现异动,股价快速拉升15.29%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发用于治疗癌症和其他疾病的新型疗法。该信息摘要如下:Ladenburg Thalmann:维持Aileron Therapeutics评级,由买入调整至买入评级, 目标价由9.00美元调整至19.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182132158b363a0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182132158b363a0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALRN"],"gpt_icon":0},{"id":"2428129345","title":"Aileron Therapeutics, Inc.盘中异动 早盘急速跳水5.05%报5.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428129345","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428129345?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:31","pubTimestamp":1713360676,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时31分,Aileron Therapeutics, Inc.股票出现波动,股价急速下挫5.05%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.67%。其相关个股中,Vanda Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Novabay Pharmaceuticals, Inc.涨幅较大,Clearmind Medicine Inc.、Novabay Pharmaceuticals, Inc.、Longeveron Inc.较为活跃,换手率分别为25.24%、21.96%、16.50%,振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Viracta Therapeutics, Inc.、Rani Therapeutics Holdings, Inc.,振幅分别为16.09%、15.75%、11.06%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发用于治疗癌症和其他疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172131168b2ffbfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172131168b2ffbfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALRN","BK4139","LENZ"],"gpt_icon":0},{"id":"2427845748","title":"Aileron Therapeutics(ALRN.US):2023年Q4财报实现营收0美元,前值为0美元;每股收益为-1.54美元,前值为-1.02美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2427845748","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427845748?lang=zh_cn&edition=full","pubTime":"2024-04-16 17:35","pubTimestamp":1713260110,"startTime":"0","endTime":"0","summary":"Aileron Therapeutics(ALRN.US):2023年Q4财报实现营收0美元,前值为0美元;每股收益为-1.54美元,前值为-1.02美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161735138783a45a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161735138783a45a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALRN","LENZ"],"gpt_icon":0},{"id":"2427832070","title":"Aileron Therapeutics Inc 报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2427832070","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427832070?lang=zh_cn&edition=full","pubTime":"2024-04-16 06:10","pubTimestamp":1713219017,"startTime":"0","endTime":"0","summary":" * Aileron Therapeutics Inc 报告,截至12月底的季度调整后每股亏损1.54美元,低于去年同期的每股收益1.02美元。分析师对该季度的唯一预测是每股亏损 16 美分。* Aileron Therapeutics Inc 公布的本季度每股收益为亏损 1.54 美元。* 该公司当季亏损 734 万美元。* Aileron Therapeutics Inc 本季度股价下跌了 7.4%,今年迄今为止上涨了 101.4%。华尔街对 Aileron Therapeutics Inc 的 12 个月目标价中位数为 9.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4139","ALRN"],"gpt_icon":0},{"id":"2427006720","title":"Aileron Therapeutics, Inc.盘中异动 早盘股价大跌6.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427006720","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427006720?lang=zh_cn&edition=full","pubTime":"2024-04-15 21:45","pubTimestamp":1713188757,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日21时45分,Aileron Therapeutics, Inc.股票出现波动,股价急速跳水6.84%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.20%。其相关个股中,安皮奥制药、Soligenix, Inc.、Longeveron Inc.涨幅较大,Allarity Therapeutics, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃,换手率分别为678.27%、614.20%、601.86%,振幅较大的相关个股有Soligenix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Longeveron Inc.,振幅分别为79.05%、73.68%、65.68%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发用于治疗癌症和其他疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041521455787e80739&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041521455787e80739&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALRN"],"gpt_icon":0},{"id":"2422862194","title":"Aileron Therapeutics, Inc.盘中异动 快速跳水6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422862194","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422862194?lang=zh_cn&edition=full","pubTime":"2024-03-28 21:36","pubTimestamp":1711632964,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日21时36分,Aileron Therapeutics, Inc.股票出现异动,股价快速下跌6.07%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.03%。其相关个股中,Avalo Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Nutriband Inc C/Wts 涨幅较大,Avalo Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Ibio, Inc.较为活跃,换手率分别为454.26%、364.62%、357.18%,振幅较大的相关个股有Avalo Therapeutics, Inc.、Nutriband Inc C/Wts 、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为71.16%、41.04%、31.00%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发用于治疗癌症和其他疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328213605791d9d56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328213605791d9d56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALRN"],"gpt_icon":0},{"id":"2422525915","title":"Aileron Therapeutics, Inc.盘中异动 股价大跌8.63%报5.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422525915","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422525915?lang=zh_cn&edition=full","pubTime":"2024-03-26 00:58","pubTimestamp":1711385908,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日00时58分,Aileron Therapeutics, Inc.股票出现波动,股价大幅下跌8.63%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。其相关个股中,Landos Biopharma, Inc.、Clene Inc C/Wts 30/12/2025 、Altamira Therapeutics Ltd.涨幅较大,Altamira Therapeutics Ltd.、Xtl生物制药、Salarius Pharmaceuticals, Inc.较为活跃,换手率分别为3206.49%、442.21%、76.48%,振幅较大的相关个股有Xtl生物制药、Altamira Therapeutics Ltd.、Zura Bio Limited,振幅分别为78.61%、74.57%、47.80%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发用于治疗癌症和其他疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326005829791cb1cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326005829791cb1cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ALRN"],"gpt_icon":0},{"id":"2421848368","title":"Aileron Therapeutics, Inc.盘中异动 急速拉升5.47%报5.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421848368","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421848368?lang=zh_cn&edition=full","pubTime":"2024-03-22 22:47","pubTimestamp":1711118848,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日22时47分,Aileron Therapeutics, Inc.股票出现波动,股价大幅上涨5.47%。Aileron Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.13%。其相关个股中,Outlook Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Effector Therapeutics Inc C/Wts 31/12/2025 涨幅较大,Outlook Therapeutics, Inc.、180 Life Sciences Corp.、Adial Pharmaceuticals, Inc较为活跃,换手率分别为72.12%、28.86%、17.24%,振幅较大的相关个股有Matinas Biopharma Holdings, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nutriband Inc C/Wts ,振幅分别为53.68%、43.92%、43.00%。Aileron Therapeutics, Inc.公司简介:Aileron Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发用于治疗癌症和其他疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032222472887e7b155&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032222472887e7b155&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALRN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aileronrx.com","stockEarnings":[{"period":"1week","weight":-0.0222},{"period":"1month","weight":-0.0404},{"period":"3month","weight":-0.2729},{"period":"6month","weight":-0.2695},{"period":"1year","weight":0.5765},{"period":"ytd","weight":0.0136}],"compareEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1285},{"period":"6month","weight":0.1855},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.1884}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aileron Therapeutics, Inc.于2001年8月6日根据特拉华州的法律成立为Renegade Therapeutics,Inc.,于2006年开始主营业务。2007年2月,公司修改其注册证书,将其名称改为Aileron Therapeutics ,Inc.该公司是一家临床阶段的生物制药公司,专注于开发和商业化一类新型的治疗剂,称为装订肽。该公司的首席候选产品ALRN-6924针对肿瘤抑制基因p53来治疗各种各样的癌症。目前正在多个临床试验中测试的ALRN-6924通过靶向两种初级p53抑制蛋白MDMX和MDM2来重新激活p53介导的肿瘤抑制。该公司正在进行的ALRN-6924临床试验包括用于治疗晚期实体瘤或淋巴瘤的第1期试验,用于治疗外周T细胞淋巴瘤的2a期试验,或PTCL治疗急性期的1期试验骨髓性白血病或AML和晚期骨髓增生异常综合征或MDS,作为单一疗法和用于治疗与胞嘧啶阿拉伯糖苷或Ara-C组合的AML / MDS的1b期试验。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.225592},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.048516},{"month":3,"riseRate":0.428571,"avgChangeRate":0.007},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.042375},{"month":5,"riseRate":0.571429,"avgChangeRate":0.182785},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.113969},{"month":7,"riseRate":0.25,"avgChangeRate":-0.150516},{"month":8,"riseRate":0.428571,"avgChangeRate":0.117019},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.009358},{"month":10,"riseRate":0,"avgChangeRate":-0.1582},{"month":11,"riseRate":0.285714,"avgChangeRate":0.015436},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.045686}],"exchange":"NASDAQ","name":"Aileron Therapeutics Inc","nameEN":"Aileron Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.0","shortVersion":"4.25.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aileron Therapeutics Inc(ALRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aileron Therapeutics Inc(ALRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aileron Therapeutics Inc,ALRN,Aileron Therapeutics Inc股票,Aileron Therapeutics Inc股票老虎,Aileron Therapeutics Inc股票老虎国际,Aileron Therapeutics Inc行情,Aileron Therapeutics Inc股票行情,Aileron Therapeutics Inc股价,Aileron Therapeutics Inc股市,Aileron Therapeutics Inc股票价格,Aileron Therapeutics Inc股票交易,Aileron Therapeutics Inc股票购买,Aileron Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aileron Therapeutics Inc(ALRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aileron Therapeutics Inc(ALRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}